TRxADE HEALTH (NASDAQ:MEDS) Trading Down 3.5% – What’s Next?

TRxADE HEALTH, Inc. (NASDAQ:MEDS)’s share price was down 3.5% during trading on Tuesday . The stock traded as low as $7.78 and last traded at $7.83. Approximately 32,477 shares were traded during trading, a decline of 84% from the average daily volume of 207,831 shares. The stock had previously closed at $8.12.

TRxADE HEALTH Stock Up 0.9 %

The business has a 50 day moving average price of $7.27 and a two-hundred day moving average price of $8.54.

TRxADE HEALTH (NASDAQ:MEDS) last announced its quarterly earnings data on Friday, August 9th. The company reported ($1.04) earnings per share (EPS) for the quarter. TRxADE HEALTH had a negative net margin of 149.81% and a negative return on equity of 196.79%. The business had revenue of $0.02 million during the quarter.

Institutional Trading of TRxADE HEALTH

An institutional investor recently bought a new position in TRxADE HEALTH stock. Virtu Financial LLC bought a new stake in shares of TRxADE HEALTH, Inc. (NASDAQ:MEDS) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 10,617 shares of the company’s stock, valued at approximately $109,000. Virtu Financial LLC owned 0.75% of TRxADE HEALTH as of its most recent SEC filing. 5.68% of the stock is owned by institutional investors and hedge funds.

TRxADE HEALTH Company Profile

TRxADE HEALTH, Inc operates as a health services information technology (IT) company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement; and designs, develops, owns, and operates a business-to-business web-based marketplace.